Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb
Clinical trial NCT04462445 · COMPLETED
Trial details
- NCT number
- NCT04462445
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-25
- Primary completion
- 2017-02-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.